For the quarter ending 2025-12-31, SNOA has $13,623K in assets. $10,191K in debts. $2,561K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Cash and cash equivalents | 2,561 | 3,035 | 3,605 | |
| Accounts receivable, net | 2,382 | 2,703 | 2,602 | |
| Inventories, net | 3,703 | 3,634 | 3,802 | |
| Prepaid expenses and other current assets | 3,351 | 2,925 | 2,868 | |
| Current portion of deferred consideration, net of discount | 148 | 204 | 230 | |
| Total current assets | 12,145 | 12,501 | 13,107 | |
| Property and equipment, net | 314 | 284 | 301 | |
| Operating lease, right of use assets | 642 | 479 | 536 | |
| Deferred tax asset, net | 458 | 508 | 546 | |
| Deferred consideration, net of discount, less current portion | 0 | 0 | 24 | |
| Other assets | 64 | 84 | 80 | |
| Total assets | 13,623 | 13,856 | 14,594 | |
| Accounts payable | 1,646 | 1,404 | 2,046 | |
| Accrued expenses and other current liabilities | 2,111 | 2,024 | 1,836 | |
| Deferred revenue, current portion | 314 | 750 | 731 | |
| Short-term debt | 0 | 56 | 139 | |
| Operating lease liabilities, current portion | 146 | 88 | 96 | |
| Total current liabilities | 4,217 | 4,322 | 4,848 | |
| Deferred revenue, net of current portion | 0 | 0 | 4 | |
| Withholding tax payable | 5,465 | 5,356 | 5,246 | |
| Operating lease liabilities, less current portion | 509 | 391 | 440 | |
| Total liabilities | 10,191 | 10,069 | 10,538 | |
| Additional paid-in capital | 207,023 | 206,733 | 206,673 | |
| Accumulated deficit | -200,400 | -199,581 | -199,047 | |
| Accumulated other comprehensive loss | -3,191 | -3,365 | -3,570 | |
| Total stockholders equity | 3,432 | 3,787 | 4,056 | |
| Total liabilities and stockholders equity | 13,623 | 13,856 | 14,594 | |
Sonoma Pharmaceuticals, Inc. (SNOA)
Sonoma Pharmaceuticals, Inc. (SNOA)